and
the
of
cholesterol
levels
with
pemafibrate
in
a
mg
triglyceride
to
cardiovascular
per
deciliter
lower
incidence
patients
or
was
for
events
2
level
lipoprotein
placebo
among
lipid
density
hdl
not
adverse
low
ldl
4
apolipoprotein
those
j
lowering
risk
high
associated
but
type
diabetes
mild
moderate
hypertriglyceridemia
receive
0
were
therapy
effects
primary
end
point
disease
median
25
8
vldl
6
remnant
c
iii
b
group
1
who
received
2022
nov
24
387
21
1923
1934
g
s
m
e
reduce
pubmedtwitterfacebooklinkedingithubsm
twittersm
facebooksm
background
are
increased
whether
reductions
these
would
is
uncertain
selective
peroxisome
proliferator
activated
receptor
α
modulator
reduces
improves
other
methods
multinational
double
blind
randomized
controlled
trial
we
assigned
200
499
40
tablets
twice
daily
matching
eligible
receiving
guideline
directed
could
statin
without
had
100
efficacy
composite
nonfatal
myocardial
infarction
ischemic
stroke
coronary
revascularization
death
from
causes
results
10
497
66
9
previous
baseline
fasting
271
33
78
follow
up
3
years
as
compared
on
at
months
26
triglycerides
very
transported
rich
lipoproteins
after
lipolysis
remodeling
27
event
occurred
572
560
hazard
ratio
03
95
confidence
interval
91
15
no
apparent
effect
modification
any
prespecified
subgroup
overall
serious
did
differ
significantly
between
groups
higher
renal
venous
thromboembolism
nonalcoholic
fatty
liver
conclusions
than
although
lowered
funded
by
kowa
research
institute
prominent
clinicaltrials
gov
number
nct03071692
das
pradhanrobert
glynnjean
charles
fruchartjean
macfadyenelaine
zaharrisbrendan
everettstuart
campbellryu
oshimapierre
amarencodirk
blomeliot
brintonrobert
h
eckelmarshall
elamjoão
feliciohenry
n
ginsbergassen
goudevshun
ishibashijacob
josephtatsuhiko
kodamawolfgang
koeniglawrence
leiteralberto
lorenzattiboris
mankovskynikolaus
marxbørge
nordestgaarddénes
pállkausik
k
rayraul
d
santoshandrean
soranandrey
susekovmichal
tenderakoutaro
yokotenina
p
paynterjulie
buringpeter
libbypaul
ridkerprominent
youtubetriglyceride
youtube
aruna
investigatorsaruna
investigators
